Misoone (Misoprostol)

Misoprostol, the active ingredient in Misoone, is a Prostaglandin E1 analog presented as an oral formulation for systemic use. It is employed to protect the gastric lining in patients taking non‑steroidal anti‑inflammatory drugs and to induce uterine contraction for obstetric indications.

GNH USA supplies Misoone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable global distribution while ensuring batch‑to‑batch consistency and regulatory support for its customers.

Misoprostol acts on prostaglandin pathways to address gastrointestinal and obstetric conditions.

- Prevention of NSAID‑induced gastric ulcers: reduces ulcer risk by increasing gastric mucus and bicarbonate secretion. - Medical termination of pregnancy: induces uterine contraction to facilitate expulsion of gestational tissue. - Induction of labor: promotes cervical softening and uterine activity to initiate childbirth. - Cervical ripening before surgical procedures: prepares the cervix for operative interventions such as dilation and curettage.

Misoprostol may cause a range of adverse reactions.

Common Side Effects: - Diarrhea: frequent loose stools. - Abdominal pain: cramping or discomfort in the stomach area. - Nausea: feeling of sickness or urge to vomit. - Fever: mild elevation of body temperature. - Uterine cramping: painful uterine contractions.

Serious or Rare Side Effects: - Severe uterine bleeding: heavy vaginal hemorrhage requiring medical attention. - Uterine rupture: tearing of the uterine wall, a medical emergency. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe diarrhea leading to dehydration. - Hyperthermia: markedly high fever.

Before prescribing Misoone, clinicians should consider several safety measures.

- Assess renal function: adjust use in patients with impaired kidney function. - Avoid in known hypersensitivity: do not give to patients with allergy to misoprostol or related prostaglandins. - Use cautiously in cardiovascular disease: monitor for potential exacerbation of ischemic conditions. - Monitor for infection signs: especially when used for uterine indications. - Avoid concurrent use with other prostaglandin analogs: may increase risk of uterine hyperstimulation. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Misoprostol can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - NSAIDs: may diminish gastroprotective effect. - Oxytocin: combined use can cause excessive uterine contraction. - Other misoprostol‑containing products: risk of overdose.

Moderate Interactions (Monitor Closely): - Antacids: may alter absorption of misoprostol. - CYP450 inhibitors: can increase plasma concentrations. - Diuretics: may heighten risk of electrolyte imbalance.